← Open Payments lookup

WALEED KHALIL: Open Payments

NPI 1700879723 · NEWBURGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$660 in 35 payments from 11 companies in 2025. Trend: 2023 $696 · 2024 $1,114 · 2025 $660

Food & beverage: $660
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC16$236
GENZYME CORPORATION4$125
PFIZER INC.5$79
Intercept Pharmaceuticals, Inc.2$43
Ardelyx, Inc.1$34
Madrigal Pharmaceuticals2$30
Janssen Biotech, Inc.1$27
ABBVIE INC.1$24
Olympus America Inc.1$24
Phathom Pharmaceuticals, Inc.1$20

Products named: XIFAXAN, DUPIXENT, XELJANZ, OCALIVA, IBSRELA, REZDIFFRA, TREMFYA, CREON.

Industry payments across NY — which companies pay providers there.